Apple Is Taking On Its First Clinical Study
The tech giant is making another move into the health market via a partnership with pharmaceutical company GlaxoSmithKline
Apple has formed a partnership with the British drug company GlaxoSmithKline, in order to conduct a clinical study on rheumatoid arthritis. The three-month study will rely on the iPhone’s ResearchKit, a diagnosis tool designed by Apple.
Using the iPhone’s sensors GSK will be able to monitor patients’ symptoms such as fatigue and joint pain. They will also be prompted to answer health related questions.
The results from this trial will be a determining factor weather the drug company decides to use Apple in the future for other clinical studies. It is also a step further into the medical field for a company that has been trying to break into the health market.
To move beyond novelty activations and one-time gimmicks, PSFK equips marketers with the insights, templates and analytics to develop high-reach campaigns that meet consumers in the moment, collect and build upon experiential data, and build scale through content creation.
Wearable X CEO Billie Whitehouse spoke to PSFK 2017 about designing wearables for all five senses and maintaining a sense of humor